CYTYC Message Board - Msg: 3430614

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTYC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Frank Buck who wrote (78)	2/13/1998 9:29:00 PM
From: Alfredo Nova	of 79

To Frank and all: I apologize for having started the thread and not having followed diligently on a regular basis. For one thing, I should have kept the stock, but I took a short term gain of 7.5 points on 1000 shares last year. Anyway, I have been seeing many insurances and HMOs who like the Thinprep and have approved it for reimbursement. The company seems to have good marketing. Now comes BC/BS. The reality is that most Ob-Gyn would like to offer the latest in technology in such a critical area of clinical Gynecology. If the FDA says that Thinprep is better than the old Pap and you don't use it, you may also have a legal problem if a patient will develop cancer after having a "normal" Pap in your office. However, labs people (Pathologists etc) have mixed feelings. They like the slides, but worry about the extra cost. The current Pap is already very effective in preventing cancer. It is essentially unheard of for a patient to have normal Paps for 5-6 years and then suddenly show cancer. But it does happen. Thinprep may be helpful here. I would say that it has good potential, but the market forces which are so powerful in Medicine today may think differently. regards, Alfredo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext